Company intelligence / Profile preview

Pro-Duct Health

Menlo Park, California, United States

Ownership: Private
Development stage: Other

Overview

Pro-Duct Health was a U.S. private medical device company focused on women's health and breast cancer risk assessment. The company developed an FDA-approved ductal lavage device, commonly referred to as the Pro-Duct Catheter, designed to non-invasively collect breast duct epithelial cells to help evaluate breast cancer risk. Its products were positioned as diagnostic and risk-evaluation tools rather than therapeutics, placing the company in the medtech/diagnostics segment of healthcare. Pro-Duct Health was acquired by Cytyc in 2001, and it no longer operates as an independent company.

Therapeutic areas: Oncology
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Pro-Duct Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pro-Duct Health.

Explore the full profile